Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial.

Q2 Medicine

Clinical Diabetes Pub Date : 2025-02-24 eCollection Date: 2025-01-01 DOI:10.2337/cd24-0104

Sean M Oser, Melissa S Putman, Steven J Russell, Elizabeth B Westfeldt, Kelsey B Huss, Britney K Prince, Jessica A Parascando, Mollie Y O'Connor, Amy Sabean, Annabelle L Ashley, Evelyn G Greaux, Rachel J Bartholomew, Sarah Gaston, Nillani Anandakugan, Hui Zheng, Courtney A Balliro, Mallory A Hillard, Edward R Damiano, Tamara K Oser

{"title":"Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial.","authors":"Sean M Oser, Melissa S Putman, Steven J Russell, Elizabeth B Westfeldt, Kelsey B Huss, Britney K Prince, Jessica A Parascando, Mollie Y O'Connor, Amy Sabean, Annabelle L Ashley, Evelyn G Greaux, Rachel J Bartholomew, Sarah Gaston, Nillani Anandakugan, Hui Zheng, Courtney A Balliro, Mallory A Hillard, Edward R Damiano, Tamara K Oser","doi":"10.2337/cd24-0104","DOIUrl":null,"url":null,"abstract":"<p><p>The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.</p>","PeriodicalId":39894,"journal":{"name":"Clinical Diabetes","volume":"43 3","pages":"388-398"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304562/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd24-0104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.

Abstract Image

查看原文本刊更多论文

评估iLet仿生胰腺在初级保健和远程医疗中的应用：一项随机临床试验。

iLet仿生胰腺系统具有简单的界面、设置和维护，可以改善1型糖尿病患者的血糖水平，使其可用于初级保健环境和远程医疗（TH）。这项多地点、随机顺序交叉试验包括40名成人1型糖尿病患者，他们接受内分泌科或初级保健诊所的治疗，并亲自或通过TH就诊。在这40名参与者中，97%达到了平均血糖（AG）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Diabetes Medicine-Internal Medicine

CiteScore

4.30

自引率

0.00%

发文量

期刊介绍： The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials.